Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
OTC Drugs

Electronic Sales Tracking To Limit Meth Production Reaches N.C., Texas

This article was originally published in The Tan Sheet

  • News

Executive Summary

North Carolina and Texas join the list of states using electronic tracking to help prevent purchases of pseudoephedrine-containing OTC drugs diverted to manufacturing methamphetamine.

You may also be interested in...



In Brief

Watson acquires Australian OTC firm; childproof packaging for imidazoline; Supplement Facts box update delayed; more news In Brief

In Brief

Okla. AG opposes local Rx-only PSE laws

In Brief

Okla. AG opposes local Rx-only PSE laws

Table

View full table

Related Content

Pink Sheet
Pink Sheet

Topics

Tags:
OTC Drugs
Latest Headlines

AstraZeneca/Sanofi’s Nirsevimab Nears US FDA Approval After Overwhelmingly Positive Adcomm

FDA’s Office Of Generic Drugs Gets New Permanent Director And Oversight Designee

Big Drug, Small Panel: US FDA Adcomm For Eisai/Biogen’s Leqembi Includes Only Six Voting Members

US FDA Balances Urgent Need For Platinum Chemotherapies Against Intas Plant’s Quality Failures

See All
UsernamePublicRestriction

Register

PS105136

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By